Mesenchymal stromal cells, colony-forming unit fibroblasts, from bone marrow of untreated advanced breast and lung cancer patients suppress fibroblast colony formation from healthy marrow

Stem Cells and Development

Volumn 19, Issue 3, 2010, Pages 359-369

  Hofer, Erica Leonor ^a,b   Labovsky, Vivian ^b,c   La Russa, Vincent ^d   Vallone, Valeria Fernández ^b,c   Honegger, Alba Elizabeth ^b   Belloc, Carlos Gabriel ^b   Wen, Huei Chi ^b   Bordenave, Raúl Horacio ^e   Bullorsky, Eduardo Oscar ^f   Feldman, Leonardo ^g   Chasseing, Norma Alejandra ^b,h  

^a Tecnològica y de Innovaciòn Productiva ^*  (Argentina)

^b INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^c Técnicas de la Repüblica Argentina ^*  (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e Department of Oncology   (Argentina)

^f HOSPITAL BRITÁNICO DE BUENOS AIRES   (Argentina)

^g HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

^h Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

DICKKOPF 1 PROTEIN; FIBROBLAST GROWTH FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ARTICLE; BREAST CANCER; CANCER PATIENT; CELL MATURATION; CELL PROLIFERATION; CELL RENEWAL; CELL STRUCTURE; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; FIBROBLAST; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CANCER; MESENCHYMAL STEM CELL; MICROENVIRONMENT; MICROMETASTASIS; PRIORITY JOURNAL;

BONE MARROW CELLS; BREAST NEOPLASMS; CELL PROLIFERATION; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; CULTURE MEDIA, CONDITIONED; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MESENCHYMAL STEM CELLS; STEM CELLS; STROMAL CELLS; TIME FACTORS;

BOVINAE;

EID: 77949615445     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2008.0375     Document Type: Article

References (50)

1. Eaves CJ, JD Cashman and AC Eaves. (1991). Methodology of long-term culture of human hematopoietic cells. J Tissue Culture Methods 13:55-62.
2. Janowska-Wieczorek A, M Majka, J Ratajczak and MZ Ratajczak. (2002). Autocrine/paracrine mechanisms in human hematopoiesis. Stem Cells 19:99-107.
3. Gregory CA, J Ylostalo and DJ Prockop. (2005). Adult bone marrow stem/progenitor cells (MSCs) are preconditioned by microenvironmental "niches" in culture: a two-stage hypothesis for regulation of MSC fate. Sci STKE 294:pe 37.
4. Chen XD, V Dusevich, JQ Feng, SC Manolagas and RL Jilka. (2007). Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts. J Bone Miner Res 22:1943-1956.
5. Dexter TM, TD Allen and LG Lajtha. (1976). Conditions controlling the proliferation of hematopoietic stem cells in-vitro. J Cell Physiol 91:335-344.
6. Fernandez M and JJ Minguell. (1984). The role of collagen in hematopoiesis: an interpretative review. Exp Hematol 12:139-146.
7. Gronthos S, AC Zannettino, SJ Hay, S Shi, SE Graves, A Kortesidis and Simmons PJ. (2003). Molecular and cellular characterisation of highly purifi ed stromal stem cells derived from human bone marrow. J Cell Sci 116:1827-1835.
8. Bianco P, M Riminucci, S Gronthos and P Gehron Robey. (2001). Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19:180-192.
9. Tocci A and L Forte. (2003). Mesenchymal stem cell: use and perspectives. Hematol J 4:92-96.
10. Minguell JJ, A Erices and P Conget. (2001). Mesenchymal stem cells. Exp Biol Med 226:507-520.
11. Rahaman MN and JJ Mao. (2005). Stem cell-based composite tissue constructs for regenerative Medicine. Biotechnol Bioeng 20:1-24.
12. Pountos I and PV Giannoudis. (2005). Biology of mesenchymal stem cells. Injury 36S:8-12.
13. Colter DC, R Class, CM DiGirolamo and DJ Prockop. (2000). Rapid expansion of recycling stem cells in cultures of plasticadherent cells from human bone marrow. Proc Natl Acad Sci USA 97:3213-3218.
14. DiGirolamo CM, D Stokes, D Colter, DG Phinney, R Class and DJ Prockop. (1999). Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifi es samples with the greatest potential to propagate and differentiate. Br J Haematol 107:275-281.
15. Baksh D, L Song and RS Tuan. (2004). Adult mesenchymal stem cells: characterization and application in cell and gene therapy. J Cell Mol Med 8:301-316.
16. Gordon MY. (1994). Physiology and function of the haematopoietic microenvironment. Br J Haematol 86:241-242.
17. Bonyadi M, SD Waldman, D Liu, JE Aubin, MD Grynpas and WL Stanford. (2003). Mesenchymal progenitor self-renewal defi - ciency leads to age-dependent osteoporosis in Sca-1/Ly-6A null mice. Proc Natl Acad Sci USA 100:5840-5845.
18. Compston JE. (2002). Bone marrow and bone: a functional unit. J Endocrinol 173:387-394.
19. Ben Baruch A. (2003). Host microenvironment in breast cancer development: infl ammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions. Breast Cancer Res 5:31-36.
20. Honegger AE, EL Hofer, RI Baranao, TA Mackinlay, DA Mackinlay, EO Bullorsky, RH Bordenave and NA Chasseing. (2002). Interleukin-1 beta, transforming growth factor beta 1, prostaglandin E2, and fi bronectin levels in the conditioned mediums of bone marrow fi broblast cultures from lung and breast cancer patients. Ann Hematol 81:80-85.
21. Chasseing NA, E Hofer, RH Bordenave, C Shanley and LS Rumi. (2001). Bone marrow fi broblasts in patients with advanced lung cancer. Braz J Med Biol Res 34:1457-1463.
22. Chasseing NA, YG Trejo, RH Bordenave, EO Bullorsky, NB Diaz and LS Rumi. (1997). Bone marrow fi broblastic progenitors in patients with advanced breast cancer. Breast Cancer Res Treat 45:211-218.
23. Chasseing NA, RH Bordenave, EO Bullorsky, NB Diaz, GR Stemmelin and LS Rumi. (1997). Fibroblastic colony-forming units and levels of tumor necrosis factor and prostaglandin E2 in bone marrow cultures from patients with advanced lung carcinoma. Cancer 80:1914-1919.
24. Castro-Malaspina H, RE Gay, G Resnick, N Kapoor, P Meyers, D Chiarieri, S McKenzie, HE Broxmeyer and MA Moore. (1980). Characterization of human bone marrow fi broblast colonyforming cells (CFU-F) and their progeny. Blood 56:289-301.
25. Koller MR, RJ Maher, I Manchel, M Oxender and AK Smith. (1998). Alternatives to animal sera for human bone marrow cell expansion: human serum and serum-free media. J Hematother 7:413-423.
26. Castro-Malaspina H. (1984). Myelofi brosis and the biology of connective tissue. In: Progress in clinical and Biological Research, vol.154. Berck PD, H Castro Malaspina, LR Wasserman, eds. Alan R. Liss Inc, New York.
27. Neuhuber B, SA Swanger, L Howard, A Mackay and I Fischer. (2008). Effects of plating density and culture time on bone marrow stromal cell characteristics. Exp Hematol 36:1176-1185.
28. Sekiya I, BL Larson, JR Smith, R Pochampally, JG Cui and DJ Prockop. (2002). Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 20: 530-541.
29. Scutt A and P Bertram. (1999). Basic fi broblast growth factor in the presence of dexamethasone stimulates colony formation, expansion, and osteoblastic differentiation by rat bone marrow stromal cells. Calcif Tissue Int 64:69-77.
30. Imaizumi T, F Jean-Louis, ML Dubertret, C Bailly, L Cicurel, JP Petchot-Bacque and L Dubertret. (1996). Effect of human basic fi broblast growth factor on fi broblast proliferation, cell volume, collagen lattice contraction: in comparison with acidic type. J Dermatol Sci 11:134-141.
31. Prockop DJ, CA Gregory and JL Spees. (2003). One strategy for cell and gene therapy: Harnessing the power of adult stem cells to repair tissues. Proc Natl Acad Sci USA 100:11917-11923.
32. Hofer EL, A Hernaldo Insua, V Fernandez Vallone, L Feldman, RH Bordenave and NA Chasseing. (2007). Plasticity of mesenchymal stem cell from bone marrow of patients with lung and breast cancer. Biocell (Argentina) 31(2):abstract 7, p. 327.
33. Fernandez M and JJ Minguell. (1996). Adhesive interactions in the hematopoietic system: regulation by cytokines. Proc Soc Exp Biol Med 212:313-323.
34. Xu YX, HB Lu and GS Zhang. (2000). Effects of rhGM-CSF and rhG-CSF on growth of CFU-F derived from acute leukemia (AL) patient bone marrow in vitro. Hunan Yi Ke Da Xue Xue Bao 25:185-187.
35. Gregory CA, H Singh, AS Perry and DJ Prockop. (2003). The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. J Biol Chem 278:28067-28078.
36. Zorn AM. (2001). Wnt signalling: antagonistic Dickkopfs. Curr Biol 11:R592-R595.
37. Rougier F, F Dupuis and Y Denizot. (1996). Human bone marrow fi broblasts-an overview of their characterization, proliferation and infl ammatory mediator production. Hematol Cell Ther 38:241-246.
38. Kimura A, O Katoh and A Kuramoto. (1988). Effects of platelet derived growth factor, epidermal growth factor and transforming growth factor-beta on the growth of human marrow fi broblasts. Br J Haematol 69:9-12.
39. Kuznetsov SA, AJ Friedenstein and PG Robey. (1997). Factors required for bone marrow stromal fi broblast colony formation in-vitro. Br J Haematol 97:561-570.
40. Kwon BS, S Wang, N Udagawa, V Haridas, ZH Lee, KK Kim, KO Oh, J Greene, Y Li, J Su, R Gentz, BB Aggarwal and J Ni. (1998). TR1, a new member of the tumor necrosis factor receptor superfamily, induces fi broblast proliferation and inhibits osteoclastogenesis and bone resorption. FASEB J 12:845-854.
41. Wilkims BS and DB Jones. (1996). Contribution of monocyte/ macrophage differentiation to the stromal layer in human longterm bone marrow cultures. Biological 24:313-318.
42. Kimura A, O Katoh, H Hyodo, S Kusumi and A Kuramoto. (1991). Autocrine and/or paracrine mechanism operate during the growth of human bone marrow fi broblasts. Br J Haematol 78:469-473.
43. Horwitz EM. (2004). Dkk-1 mediated expansion of adult stem cells. Trends Biotechnol 22:386-388.
44. Tamama K, VH Fan, LG Griffi th, HC Blair and A Wells. (2006). Epidermal growth factor as a candidate for ex-vivo expansion of bone marrow derived mesenchymal stem cells. Stem Cells 24:686-695.
45. Ng F, S Boucher, S Koh, KS Sastry, L Chase, U Lakshmipathy, C Choong, Z Yang, MC Vemuri, MS Rao and V Tanavde. (2008). PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profi ling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood 112:295-307.
46. Bryckaert MC, M Lindroth, A Lonn, G Tobelem and A Wasteson. (1988). Transforming growth factor (TGF beta) decreases the proliferation of human bone marrow fi broblasts by inhibiting the platelet-derived growth factor (PDGF) binding. Exp Cell Res 179:311-321.
47. Friedenstein AJ, NV Latzinik, YF Gorskaya, EA Luria and IL Moskvina. (1999). Bone marrow stromal colony formation requires stimulation by haemopoietic cells. Bone Miner 18:199-213.
48. Yamada M, S Suzu, M Tanaka-Douzono, N Wakimoto, K Hatake, H Hayasawa and K Motoyoshi. (2000). Effect of cytokines on the proliferation/differentiation of stroma-initiating cells. J Cell Physiol 184:351-355.
49. Fromigue O, D Modrowski and PJ Marie. (2004). Growth factors and bone formation in osteoporosis: roles for fi broblast growth factor and transforming growth factor beta. Curr Pharm Des 10:2593-2603.
50. Hofer EL, V LaRussa, AE Honegger, EO Bullorsky, RH Bordenave and NA Chasseing. (2005). Alteration on the expression of IL-1, PDGF, TGF-beta, EGF, and FGF receptors and c-Fos and c-Myc proteins in bone marrow mesenchymal stroma cells from advanced untreated lung and breast cancer patients. Stem Cells Dev 14:587-594.